MedTrace Logo

Phase 2a Study for PK/PD of nC-001

NCT06798675 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-05-29

No results posted yet for this study

Summary

CHRONIC EUVOLEMIC HYPONATREMIA

Conditions

  • CHRONIC HYPONATREMIA

Interventions

DRUG

nC-001

solid dosage form single dose

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • nephCentric

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-31
Primary Completion
2026-03-31
Completion
2026-06-30
FDA Drug
Yes

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06798675 on ClinicalTrials.gov